More recently, on October 22, 2024, Novo Nordisk, the creator of the Ozempic (semaglutide) and Wegovy (semaglutide) injections, nominated its semaglutide glucagon-like peptide 1 (GLP-1) medications to be listed
Stimulant weight loss supplements Products containing caffeine, synephrine, yohimbine, or other stimulants marketed for weight loss provide no additional benefit when you are already on tirzepatide
Conversely, conditions like PCOS may improve with weight loss, potentially restoring regular cycles after an initial period of irregularity
No, never take a double dose to catch up. This can cause a sharp increase in side effects like nausea
Since kidney stones are both painful and disruptive, it makes sense that people want to know if their treatment could increase this risk